Genzyme, Sanofi Mum On Merger Negotiations At JPM Conference
Genzyme depicts itself as the picture of health with enzyme replacement therapy business returning to normal after manufacturing woes.
Genzyme depicts itself as the picture of health with enzyme replacement therapy business returning to normal after manufacturing woes.